Biobanks Market | Growth, Trends, and Forecasts

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the Report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

9.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors for the growth of the global biobanks market include the innovations in regenerative medicine, the growing incidence of chronic diseases, advances in drug discovery and development, and R&D funding and investments by government and non-governmental organizations. These factors are expected to a boost the growth of the market over the forecast period.

Regenerative medicine through stem cell technology is one of the important treatments for diseases, such as Alzheimer's, diabetes, cancers, and rare genetic diseases. In order to benefit from the existing therapies, umbilical cord cells and other stem cells are preserved.

Stem cell practices are on the rise, globally, and are contributing to the development of new solutions for various diseases. Boston-based biotech start-up, Orig3n, is looking to build the largest and most diverse biobank, harnessing the power of induced pluripotent stem cell technology to accelerate regenerative medicine. Treatments for diseases, like muscular degeneration, using adult stem cells are now going into Phase 3 clinical trials in Japan. These successes are driving both the government and the private sector organizations into investing in more stem cell banks.

With the increase in awareness about stem cell therapies, there have been larger number of parents who are choosing umbilical cord banks for their children. There are a number of donor banks that are coming up as well. Biobanks not only aid in the therapies for genetic diseases, but also in medical research on rare genetic disorders. Increasing awareness about stem cell therapies and innovation in the field of regenerative medicine are driving the growth of the global biobank market.

Scope of the Report

As per the scope of the report, biobank is a biorepository, where various biomaterials (usually human specimens) are stored for research purpose. This study targets gaining a detailed overview of the market dynamics of the contemporary biobank market during the forecast period. It focuses on the need to develop strategic insights into the global and country-level markets, taking into consideration the demand for services and equipment in biobanks.

By Equipment

Cryogenic Storage Systems
	Refrigerators
	Ice Machines
	Freezers

Alarm Monitoring Systems

Other Equipment

By Media
		Optimized Media
		Non-optimized Media

By Services
		Human Tissue Biobanking
		Stem Cell Biobanking
		Cord Banking
		DNA/RNA Biobanking
		Other Services

By Application
		Regenerative Medicine
		Drug Discovery
		Disease Research

Geography

North America
	United States
	Canada
	Mexico

Europe
	Germany
	United Kingdom
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cryogenic Storage Segment by Equipment is Expected to Account for the Largest Market Share During the Forecast Period

In biobanks, the cryogenic storage systems are basically used to store different life sciences materials at a very low temperature. The low temperature storage increases the longevity of the cells, while at the same time reducing the intensity of freezing damage.
Various cryogenic storage devices are available that have been designed to allow storage of both liquid and vapor phase materials. The temperature in the cryogenic storage system is required to be maintained continuously.
Currently, all demand is for automated cryogenic storage devices. This segment is further divided into refrigerators, ice machines, and freezers.
The advanced storage and automated devices are propelling the growth of the market, steady growth in the North American and European markets is expected.
The increasing R&D spending is propelling the demand for biobanks which is in turn helping in the growth of the segment.

To understand key trends, Download Sample Report

North America Accounted for the Largest Share in the Global Market

North America holds a major share in the global biobanks market, and it is expected to show a similar trend over the forecast period, without significant fluctuations.
The United States has the largest expenditure for R&D and better healthcare infrastructure in the world. Different pharmaceutical/ biotech companies, academia, and research institutes are utilizing biobanks for the storage of DNA, RNA, tissue, serum, blood, plasma, cells, etc.
Hence, with the growing R%D expenditure and developed healthcare infrastructure, the region is expected to witness strong market share in the future.

To understand geography trends, Download Sample Report.

Competitive Landscape

The global biobanks market is moderately consolidated. Some of the segments are dominated by a few major players, while the other segments are distributed among multiple players. The market players are moreover, focusing on collaboration and partnership activities. For instance, BioLife Solutions and SAVSU collaborated to provide enhanced, cold-chain technologies for diabetes, lupus, pemphigus, and organ transplantation in October 2017.

Major Players

You can also purchase parts of this report. Do you want to check out a section wise price list?

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Innovations in Regenerative Medicine
  2. 4.2.2 Growing Incidences of Chronic Diseases
  3. 4.2.3 Advances in Drug Discovery and Development
  4. 4.2.4 Increasing Focus on Personalized Medicine
3. 4.3 Market Restraints
  1. 4.3.1 Regulatory Issues
  2. 4.3.2 Cost Constraints
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Equipment
  1. 5.1.1 Cryogenic Storage Systems
    1. 5.1.1.1 Refrigerators
    2. 5.1.1.2 Ice Machines
    3. 5.1.1.3 Freezers
  2. 5.1.2 Alarm Monitoring Systems
  3. 5.1.3 Other Equipment
2. 5.2 By Media
  1. 5.2.1 Optimized Media
  2. 5.2.2 Non-optimized Media
3. 5.3 By Services
  1. 5.3.1 Human Tissue Biobanking
  2. 5.3.2 Stem Cell Biobanking
  3. 5.3.3 Cord Banking
  4. 5.3.4 DNA/RNA Biobanking
  5. 5.3.5 Other Services
4. 5.4 By Application
  1. 5.4.1 Regenerative Medicine
  2. 5.4.2 Drug Discovery
  3. 5.4.3 Disease Research
5. 5.5 Geography
  1. 5.5.1 North America
    1. 5.5.1.1 United States
    2. 5.5.1.2 Canada
    3. 5.5.1.3 Mexico
  2. 5.5.2 Europe
    1. 5.5.2.1 Germany
    2. 5.5.2.2 United Kingdom
    3. 5.5.2.3 France
    4. 5.5.2.4 Italy
    5. 5.5.2.5 Spain
    6. 5.5.2.6 Rest of Europe
  3. 5.5.3 Asia-Pacific
    1. 5.5.3.1 China
    2. 5.5.3.2 Japan
    3. 5.5.3.3 India
    4. 5.5.3.4 Australia
    5. 5.5.3.5 South Korea
    6. 5.5.3.6 Rest of Asia-Pacific
  4. 5.5.4 Middle East & Africa
    1. 5.5.4.1 GCC
    2. 5.5.4.2 South Africa
    3. 5.5.4.3 Rest of Middle East & Africa
  5. 5.5.5 South America
    1. 5.5.5.1 Brazil
    2. 5.5.5.2 Argentina
    3. 5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Atlanta Biologicals Inc.
  2. 6.1.2 Becton, Dickinson and Company
  3. 6.1.3 BioLifeSolutions Inc.
  4. 6.1.4 Chart Industries Inc.
  5. 6.1.5 Hamilton Company
  6. 6.1.6 CENTOGENE N.V.
  7. 6.1.7 Sigma-Aldrich Inc. (Merck KGaA)
  8. 6.1.8 STEMCELL Technologies Inc.
  9. 6.1.9 Thermo Fisher Scientific Inc.
  10. 6.1.10 VWR International LLC

*List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments